Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes
The physiological and pathophysiological relevance of the angiotensin II type 1 (AT<sub>1</sub>) G protein-coupled receptor no longer needs to be proven in the cardiovascular system. The renin–angiotensin system and the AT<sub>1</sub> receptor are the targets of several class...
Main Authors: | Céline Delaitre, Michel Boisbrun, Sandra Lecat, François Dupuis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/6738 |
Similar Items
-
The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor
by: Gábor Turu, et al.
Published: (2019-08-01) -
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist
by: Phil Pickford, et al.
Published: (2021-09-01) -
Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors
by: Takashi Nishida, et al.
Published: (2021-08-01) -
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
by: Joaquim Azevedo Neto, et al.
Published: (2020-08-01) -
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
by: Kendall L. Mores, et al.
Published: (2019-04-01)